Clinical Trials Logo

Clinical Trial Summary

The purposes of this study are 1) to determine the pharmacokinetics of alcohol after experimental administration of alcohol simulating a "binge-drinking" episode in young adults 2) to determine the profile of biomarkers of acute damage and exposure/consumption to alcohol 3) to determine the pharmacokinetic parameters and evaluate the acute effects alcohol and its relationship with biomarkers.


Clinical Trial Description

Binge drinking (BD) has become trendy among adolescents and young adults. It is defined as a pattern of drinking that reach blood alcohol concentration (BAC) to 80 mg/dl in a short period of time (2 hours), that typically occurs after 4 drinks for women and 5 drinks for men. Despite its high prevalence and association with morbidity and mortality, there are no previous experimental studies evaluating alcohol concentrations after a "binge drinking" episode neither its effects on biomarkers of acute damage and exposure/consumption.

The aims of this study are 1) to determine the pharmacokinetics of alcohol after experimental administration of alcohol simulating a "binge-drinking" episode in young adults 2) to determine the profile of biomarkers of acute damage and exposure/consumption to alcohol 3) to determine the pharmacokinetic parameters and evaluate the acute effects alcohol and its relationship with biomarkers. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03931018
Study type Interventional
Source Fundació Institut Germans Trias i Pujol
Contact Angels Fortes, BS
Phone 34 93 497 89 56
Email ceic.germanstrias@gencat.cat
Status Recruiting
Phase N/A
Start date December 1, 2017
Completion date March 1, 2020

See also
  Status Clinical Trial Phase
Completed NCT02911077 - Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Completed NCT04473482 - Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial N/A
Completed NCT03340051 - Remote Alcohol Monitoring and Episodic Thinking N/A
Withdrawn NCT04659278 - Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use N/A
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Completed NCT02388243 - The Computer-based Drug and Alcohol Training Assessment in Kenya N/A
Completed NCT00248612 - Psychosocial and Medication Treatment for Anxiety in Alcoholism Phase 2/Phase 3
Recruiting NCT03535129 - A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder N/A
Completed NCT00142844 - Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 Phase 2
Completed NCT00000257 - Effects of Alcohol History on Effects of Nitrous Oxide - 9 N/A
Completed NCT00000278 - Disulfiram for Cocaine-Alcohol Abuse - 3 Phase 2
Recruiting NCT06074341 - TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study N/A
Not yet recruiting NCT05910580 - Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years N/A
Completed NCT02655354 - A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity N/A
Completed NCT01227980 - Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^ Phase 2
Completed NCT01344122 - Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) N/A
Completed NCT00400010 - Alcohol Expert System Intervention for Problematic Alcohol Use N/A
Completed NCT00391742 - Stepped Interventions for Problem Drinkers N/A
Completed NCT04725552 - Identifying and Managing Alcohol-related Health Problems in General Practice N/A
Completed NCT02968186 - Implementing Screening and Brief Interventions for Excessive Drinkers in Primary Health Care N/A